Table 6 Association between LV remodelling and circulating lncRNAs in patients with well-controlled type 2 diabetes.
β | P-value | β | P-value | ||
|---|---|---|---|---|---|
Model 1 | Model 1 | ||||
MIAT | 0.396 | 0.005* | SENCR | 0.345 | 0.015* |
Age | 0.172 | 0.211 | Age | 0.168 | 0.233 |
BMI | 0.305 | 0.029* | BMI | 0.236 | 0.092 |
Model 2 | Model 2 | ||||
Association between LVMV-ratio and circulating MIAT for model 2 and each of following variables: | Association between LVMV-ratio and circulating SENCR for model 2 and each of following variables: | ||||
Plasma fasting glucose | 0.411 | 0.005* | Plasma fasting glucose | 0.353 | 0.015* |
Plasma fasting insulin | 0.425 | 0.003* | Plasma fasting insulin | 0.333 | 0.021* |
Time since diagnosis of diabetes | 0.404 | 0.005* | Time since diagnosis of diabetes | 0.357 | 0.014* |
SBP | 0.385 | 0.007* | SBP | 0.334 | 0.019* |
DBP | 0.375 | 0.008* | DBP | 0.323 | 0.023* |
Heart rate | 0.390 | 0.006* | Heart rate | 0.340 | 0.017* |
Myocardial steatosis | 0.396 | 0.006* | Myocardial steatosis | 0.349 | 0.015* |
NT-proBNP | 0.401 | 0.005* | NT-proBNP | 0.365 | 0.011* |
us-CRP | 0.389 | 0.008* | us-CRP | 0.348 | 0.018* |